Intervention for Newly Diagnosed Youth With HIV

Intervention Development for Newly Diagnosed Youth With HIV

This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.

Study Overview

Detailed Description

The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.

Individual Session I: Orientation I

Part A - meet with interventionist for ecological assessment, rapport building, and preparation for meeting with medical provider Part B - meet with medical provider to answer HIV specific medical questions (i.e., transmission information, viral load/t-cells, opportunistic infections,etc.). The interventionist will be present in Part B as well.

Individual Session II: Orientation II

Part A - meet with interventionist for continued debriefing, question/answer, preparation for group participation.

Part B - meet with peer facilitator to discuss individual experiences living with HIV, rapport building, peer-specific questions. The interventionist will be present in Part B as well.

Individual session III: Wrap-up and Action Planning (to take place after group sessions are complete)

Part A - action plan with linkage to identified agencies via facilitated referrals Part B - (optional) support building - participants may bring parents, partner, friend, or other potential source of support for question/answer session with interventionist

Session I: Developing Group Cohesion

- Icebreaker, team building, group rules, facilitation of group "ownership" by participants.

Session II: Disclosure, Stigma & Relationships

  • Disclosure to family, friends, peers and co-workers as well as dealing with stigma associated with HIV/AIDS;
  • Concerns about current or future romantic and/or sexual relationships, including discussion of safer sex, condom use, sero-discordant couples.

Session III: Preparing for Medical Intervention

- Working with medical providers, an overview of clinic appointments and expectations surrounding attendance, a preliminary discussion of medications, side effects, and medical management as well as strategies for adherence.

Session IV: Healthy Living

  • Issues related to drugs and alcohol;
  • Leisure activities such as sports and entertainment;
  • Self-care including nutrition and exercise;
  • The importance of school and work.

Session V: Stress Reduction/Relaxation & Spirituality

  • Techniques including deep breathing, progressive muscle relaxation, visualization, meditation and self-hypnosis;
  • Self-care including complimentary therapies such as massage and acupuncture
  • Spirituality;
  • Planning social outings and activities.

Session VI: Gender Specific

  • Males: issues surrounding sexuality and sexual orientation, male role of caring for self, loved ones, and the community;
  • Females: issues surrounding sexuality, pregnancy and parenting, female role of caring for self, loved ones, and the community.

Session VII: Self-Esteem/Self-Worth

- Strategies to improve self-esteem and self-worth;

Session VIII: Legal Issues/Advocacy

  • Legal rights and advocacy;
  • Linkage to community advocacy groups;
  • Preparing to become a speaker/advocate;
  • Health insurance/life insurance.

Session IX: Future Planning

- Planning for the future including issues related to work and school (e.g., job application process, applying for financial aid), job training and career choices.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Miami, Florida, United States, 33101
        • University of Miami School of Medicine
    • Illinois
      • Chicago, Illinois, United States, 60612
        • John Stroger Jr. Hospital of Cook County
    • New York
      • Bronx, New York, United States, 10467
        • Montefiore Medical Center
    • Tennessee
      • Memphis, Tennessee, United States, 38105
        • St. Jude Children's Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 24 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

To be considered eligible for enrollment in ATN 068, a participant must meet the criteria listed below:

  • Receive services at one of the 4 selected ATN sites or their community partners;
  • HIV-infected as documented by medical record review or verbal verification with referring professional;
  • Received HIV diagnosis less than 15 months ago as documented by medical record review or verbal verification with referring professional;
  • Fall between the ages of 16-24 (inclusive) at the time of informed consent/assent;
  • Must be willing to participate in the both the individual and group sessions;
  • Give informed consent/assent for study participation.

Exclusion Criteria:

Participants who meet any of the exclusion criteria listed below are considered ineligible:

  • Acquired HIV through perinatal infection;
  • Presence of serious psychiatric symptoms (active hallucinations, thought disorder);
  • Visibly distraught (suicidal, homicidal, exhibiting violent behavior);
  • Intoxicated or under the influence of alcohol or other substances at the time of study enrollment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
5-7 females per group at each of the four sites.
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.
EXPERIMENTAL: 2
5-7 males per group at each of the four sites.
The intervention will consist of a combination of individual and group-based sessions in which the youth will participate. This combination allows for more intensive individualized attention as well as supportive group sessions. Youth will first participate in two individual sessions, followed by nine group sessions, and end with one additional individual session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The best procedures for a larger trial (e.g. timing, content etc. of ACASI administration)
Time Frame: 7 months
7 months
The appropriateness of specific instruments proposed.
Time Frame: 7 months
7 months
The perceived sensitivity of measures to change over time.
Time Frame: 7 months
7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sybil Hosek, PhD, John Stroger Jr. Hospital of Cook County

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2007

Primary Completion (ACTUAL)

June 1, 2008

Study Completion (ACTUAL)

January 1, 2009

Study Registration Dates

First Submitted

July 31, 2007

First Submitted That Met QC Criteria

July 31, 2007

First Posted (ESTIMATE)

August 1, 2007

Study Record Updates

Last Update Posted (ACTUAL)

March 6, 2017

Last Update Submitted That Met QC Criteria

March 2, 2017

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • ATN 068

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)

Subscribe